Aeterna Zentaris Inc. Announces Name Change To COSCIENS Biopharma Inc. To Begin Trading Under The Trading Symbol "CSCI" August 9, 2024
Aeterna Zentaris Inc. Announces Name Change To COSCIENS Biopharma Inc. To Begin Trading Under The Trading Symbol "CSCI" August 9, 2024
COSCIENS Biopharma Inc. (formerly Aeterna Zentaris Inc.) (NASDAQ:AEZS) (TSX:AEZS) ("COSCIENS" or the "Company"), a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products and active ingredients for healthcare and cosmetics industries, today announces that the Company's name has been changed from "Aeterna Zentaris Inc." to "COSCIENS Biopharma Inc.", effective as of August 6, 2024 (the "Name Change").
COSCIENS Biopharma公司（原名Aeterna Zentaris公司）（NASDAQ:AEZS）（TSX:AEZS）（「COSCIENS」或「公司」）是一家專業的生物醫藥公司，致力於開發和商業化多元化的藥品、診斷產品和醫療和化妝品行業的活性成分組合，並於今天宣佈，公司名稱由「Aeterna Zentaris公司」更名爲「COSCIENS Biopharma公司」，並自2024年8月6日（「名稱更改」）起生效。
In addition, the Company announces that, effective as of August 9, 2024, the Company's common shares (the "Common Shares") will begin trading on the Toronto Stock Exchange (the "TSX") and NASDAQ Capital Market (the "NASDAQ") under the trading symbol "CSCI" and will concurrently cease trading thereon under the former trading symbol "AEZS".
此外，公司宣佈，自2024年8月9日起，公司的普通股（「普通股」）將在多倫多證券交易所（「TSX」）和納斯達克資本市場（「納斯達克」）上開始交易，交易符號爲「CSCI」，同時將停止使用原有的交易符號「AEZS」.
